Related references
Note: Only part of the references are listed.Non-Epithelial Ovarian Cancers: How Much Do We Really Know?
Alison Cheung et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)
Revisiting the necessity for routine appendectomies in mucinous neoplasms of the ovary: An evaluation of 460 mucinous ovarian tumors
Ahlam Albloshi et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2022)
What are the implications of radiologically abnormal cardiophrenic lymph nodes in advanced ovarian cancer? An analysis of tumour burden, surgical complexity, same-site recurrence and overall survival
Susan Addley et al.
EJSO (2022)
Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes
Sidrah Shah et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)
Primary mucinous ovarian cancer: options for surgery and chemotherapy
Katherine C. Kurnit et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2022)
The outcome of patients with serous papillary peritoneal cancer, fallopian tube cancer, and epithelial ovarian cancer by treatment eras: 27 years data from the SEER registry
Nicholas Pavlidis et al.
CANCER EPIDEMIOLOGY (2021)
Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response
Brittany P. Rickard et al.
CANCERS (2021)
The untapped potential of ascites in ovarian cancer research and treatment
Caroline Elizabeth Ford et al.
BRITISH JOURNAL OF CANCER (2020)
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)
Anna Fagotti et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?
Michele Moschetta et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms
Philipp Harter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO-OVAR OP7)
Alexander Reuss et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC-IV ovarian cancer
Roberto Tozzi et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2019)
Is it necessary to perform routine appendectomy for mucinous ovarian neoplasms? A retrospective study and meta-analysis
Aoshuang Cheng et al.
GYNECOLOGIC ONCOLOGY (2017)
Appendectomy for mucinous ovarian tumors: Is it really necessary?
D.E. Vlachos et al.
GYNECOLOGIC ONCOLOGY (2016)
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
Sean Kehoe et al.
LANCET (2015)
Cancer Treatment and Survivorship Statistics, 2014
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy?
Johanna Hynninen et al.
GYNECOLOGIC ONCOLOGY (2013)
Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: Analysis of morbidity and oncological outcome
V. Gallotta et al.
EJSO (2011)
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Ignace Vergote et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Role of Surgical Outcome as Prognostic Factor in Advanced Epithelial Ovarian Cancer: A Combined Exploratory Analysis of 3 Prospectively Randomized Phase 3 Multicenter Trials By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO)
Andreas du Bois et al.
CANCER (2009)
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
Dennis S. Chi et al.
GYNECOLOGIC ONCOLOGY (2009)
Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
Michael A. Bookman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Histopathologic assessment of tumor regression after neoadjuvant chemotherapy in advanced-stage ovarian cancer
Stefanie Sassen et al.
HUMAN PATHOLOGY (2007)
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer
Eric L. Eisenhauer et al.
GYNECOLOGIC ONCOLOGY (2006)
Mechanisms of transcoelomic metastasis in ovarian cancer
David S. P. Tan et al.
LANCET ONCOLOGY (2006)
Aggressive surgical effort and improved survival in advanced-stage ovarian cancer
GD Aletti et al.
OBSTETRICS AND GYNECOLOGY (2006)
Morphological effects of chemotherapy on ovarian carcinoma
WG McCluggage et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Share Paper
